Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -42476.19% is 243% below its 5-year average of -12380.99%, near the low end of its 5-year range (-42476.19%–-2582.46%).
563.65% below its 12-month average of -6400.39%.
Reported quarterly EBITDA margin; no daily interpolation. Q1 FY2019 (2019-03-31): -10133.33%.
EBITDA MARGIN
-42476.19%
EBITDA MARGIN AVG TTM
-6400.39%
EBITDA MARGIN AVG 3Y
-12213.40%
EBITDA MARGIN AVG 5Y
-12380.99%
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-563.65%
CURRENT VS 3Y AVG
-247.78%
CURRENT VS 5Y AVG
-243.08%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Phio Pharmaceuticals Corp.
Market Cap
$11.56M
EBITDA Margin
-42476.19%
TTM Avg
-6400.39%
3Y Avg
-12213.40%
5Y Avg
-12380.99%
Market Cap
$11.43M
EBITDA Margin
-19.85%
TTM Avg
-31.46%
3Y Avg
-46.77%
5Y Avg
-56.23%
Market Cap
$11.36M
EBITDA Margin
-5625.93%
TTM Avg
-8506.17%
3Y Avg
-6687.48%
5Y Avg
-5181.84%
Market Cap
$11.12M
EBITDA Margin
28.31%
TTM Avg
28.31%
3Y Avg
28.31%
5Y Avg
-18969.31%
Market Cap
$12.19M
EBITDA Margin
-1.94%
TTM Avg
-1.94%
3Y Avg
-10.48%
5Y Avg
-10.95%
Market Cap
$10.91M
EBITDA Margin
-133689.80%
TTM Avg
-133689.80%
3Y Avg
-133689.80%
5Y Avg
-133689.80%
Market Cap
$10.84M
EBITDA Margin
-284.92%
TTM Avg
-261.31%
3Y Avg
-2315.78%
5Y Avg
-2461.07%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | $11.56M | -42476.19% | -6400.39% | -12213.40% | -12380.99% |
| Biofrontera Inc. (BFRI)vs › | $11.43M | -19.85% | -31.46% | -46.77% | -56.23% |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.36M | -5625.93% | -8506.17% | -6687.48% | -5181.84% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.32M | N/A | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.12M | 28.31% | 28.31% | 28.31% | -18969.31% |
| BioVie Inc. (BIVI)vs › | $11.04M | N/A | N/A | N/A | N/A |
| IRIDEX Corporation (IRIX)vs › | $12.19M | -1.94% | -1.94% | -10.48% | -10.95% |
| Caring Brands, Inc. (CABR)vs › | $10.91M | -133689.80% | -133689.80% | -133689.80% | -133689.80% |
| Cerenome, Inc. (CNSY)vs › | $10.84M | -284.92% | -261.31% | -2315.78% | -2461.07% |
| Polyrizon Ltd. (PLRZ)vs › | $10.83M | N/A | N/A | N/A | N/A |
Gross Margin
0.0%
EBITDA Margin
-42476.2%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2019-03-31 | -10133.33% |
| 2018-09-30 | -2582.46% |
| 2018-06-30 | -3237.93% |
| 2018-03-31 | -9647.83% |
| 2017-12-31 | -13126.67% |
| 2016-06-30 | -24455.56% |
| 2016-03-31 | -22310.00% |
| 2015-03-31 | -8602.94% |
| 2014-12-31 | -16335.71% |
| 2014-09-30 | -13643.75% |
| 2014-06-30 | -16675.00% |
| 2014-03-31 | -7820.69% |
| 2013-12-31 | -8610.34% |
| 2013-09-30 | -2223.91% |
| 2013-06-30 | -861.33% |
| 2013-03-31 | -27109.43% |
| 2012-12-31 | -4207.50% |
| 2012-09-30 | -2907.02% |
